Armistice Capital, LLC Cyclo Therapeutics, Inc. Transaction History

Armistice Capital, LLC

  • $7.34 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.82 - $2.27 $268,140 - $742,290
-327,000 Reduced 35.16%
603,000 $506,000
Q4 2022

Feb 14, 2023
BUY
$0.95 - $1.99 $883,500 - $1.85 Million
930,000 New
930,000 $1.32 Million
Q4 2020

Feb 16, 2021
BUY
$3.85 - $16.0 $385,000 - $1.6 Million
100,000 New
100,000 $435,000

Others Institutions Holding CYTH

# of Institutions
22
Shares Held
2.16M
Call Options Held
0
Put Options Held
0
View Full List

About Cyclo Therapeutics, Inc.

CYTH Quotes by TradingView
  • Ticker CYTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 8,439,440
  • Market Cap $10.5M
  • Description
  • Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...
More about CYTH
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email